Title: 
Official Title: To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.
Number of Sections: 3
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Protecting Life and Integrity in Research Act of 2025.

Section 2:
2.No research involving human fetal tissue obtained pursuant to an induced abortion(a)In general(1)In generalNo Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion.(2)Development of new, ethical cell linesSubsection (a) does not limit the authority of any Federal department, agency, or office to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion.(3)Research involving human fetal tissue obtained after a miscarriage or stillbirth permittedAny research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act (42 U.S.C. 289g–1).(b)Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirthSection 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended—(1)in the section heading, by striking transplantation of fetal tissue and inserting human fetal tissue obtained after a miscarriage or stillbirth;(2)by amending subsection (a) to read as follows:(a)Establishment of programThe Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.;(3)in subsection (b)—(A)in paragraph (1)(B), by inserting if the human fetal tissue is intended for transplantation, before the donation; and(B)in paragraph (2)—(i)by striking subparagraph (A); and(ii)by redesignating subparagraphs (B) and (C) as (A) and (B), respectively; (4)in subsection (c)(1)(B), by striking pursuant to a spontaneous or induced abortion or pursuant to and inserting after a miscarriage or; and(5)by amending subsection (g) to read as follows:(g)DefinitionsIn this section:(1)Human fetal tissueThe term human fetal tissue means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth. (2)MiscarriageThe term miscarriage means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.(3)StillbirthThe term stillbirth means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.(4)Unborn childThe term unborn child has the meaning given such term in section 1841(d) of title 18, United States Code..(c)Conforming repealSection 113 of the National Institutes of Health Revitalization Act of 1993 (42 U.S.C. 289g–1 note) is repealed.

Section 3:
3.Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion(a)In generalSection 498B(c)(1) of the Public Health Service Act (42 U.S.C. 289g–2(c)(1)) is amended to read as follows:(1)solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—(A)a human pregnancy was deliberately initiated to provide such tissue; or(B)the tissue was obtained pursuant to an induced abortion; or.(b)Conforming changesSection 498B of the Public Health Service Act (42 U.S.C. 289g–2), as amended by subsection (a), is further amended—(1)by striking subsection (b);(2)by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and(3)in subsection (c), as redesignated—(A)in paragraph (1), by striking (a), (b), or (c) and inserting (a) or (b); and(B)in paragraph (2), by striking or (b)(3).


================================================================================

Raw Text:
119 HR 2075 IH: Protecting Life and Integrity in Research Act of 2025
U.S. House of Representatives
2025-03-11
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 2075IN THE HOUSE OF REPRESENTATIVESMarch 11, 2025Mr. Onder (for himself, Mr. Smith of New Jersey, Mr. Latta, Mr. Kelly of Mississippi, Mrs. Miller of Illinois, Mr. Harris of Maryland, Mr. Green of Tennessee, Mr. LaMalfa, Mr. Grothman, Mr. Cloud, Mr. Self, Mr. Weber of Texas, Mr. Stauber, Mr. Ellzey, Mr. Ezell, Mr. Guest, Mr. Burchett, Mr. Crane, Mr. Fallon, Mrs. Biggs of South Carolina, Mr. Palmer, Mr. Biggs of Arizona, Ms. Greene of Georgia, and Mr. Fleischmann) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.1.Short titleThis Act may be cited as the Protecting Life and Integrity in Research Act of 2025.2.No research involving human fetal tissue obtained pursuant to an induced abortion(a)In general(1)In generalNo Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion.(2)Development of new, ethical cell linesSubsection (a) does not limit the authority of any Federal department, agency, or office to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion.(3)Research involving human fetal tissue obtained after a miscarriage or stillbirth permittedAny research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act (42 U.S.C. 289g–1).(b)Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirthSection 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended—(1)in the section heading, by striking transplantation of fetal tissue and inserting human fetal tissue obtained after a miscarriage or stillbirth;(2)by amending subsection (a) to read as follows:(a)Establishment of programThe Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.;(3)in subsection (b)—(A)in paragraph (1)(B), by inserting if the human fetal tissue is intended for transplantation, before the donation; and(B)in paragraph (2)—(i)by striking subparagraph (A); and(ii)by redesignating subparagraphs (B) and (C) as (A) and (B), respectively; (4)in subsection (c)(1)(B), by striking pursuant to a spontaneous or induced abortion or pursuant to and inserting after a miscarriage or; and(5)by amending subsection (g) to read as follows:(g)DefinitionsIn this section:(1)Human fetal tissueThe term human fetal tissue means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth. (2)MiscarriageThe term miscarriage means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.(3)StillbirthThe term stillbirth means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.(4)Unborn childThe term unborn child has the meaning given such term in section 1841(d) of title 18, United States Code..(c)Conforming repealSection 113 of the National Institutes of Health Revitalization Act of 1993 (42 U.S.C. 289g–1 note) is repealed.3.Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion(a)In generalSection 498B(c)(1) of the Public Health Service Act (42 U.S.C. 289g–2(c)(1)) is amended to read as follows:(1)solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—(A)a human pregnancy was deliberately initiated to provide such tissue; or(B)the tissue was obtained pursuant to an induced abortion; or.(b)Conforming changesSection 498B of the Public Health Service Act (42 U.S.C. 289g–2), as amended by subsection (a), is further amended—(1)by striking subsection (b);(2)by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and(3)in subsection (c), as redesignated—(A)in paragraph (1), by striking (a), (b), or (c) and inserting (a) or (b); and(B)in paragraph (2), by striking or (b)(3).